Paolo Milani Selected Research

Cardiomyopathies (Cardiomyopathy)

12/2019	An evaluation of patisiran: a viable treatment option for transthyretin-related hereditary amyloidosis.
1/2019	Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient.
6/2016	Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo Milani Research Topics

Disease

49	Immunoglobulin Light-chain Amyloidosis 11/2022 - 11/2010
17	Amyloidosis 03/2022 - 04/2014
8	Choroidal Neovascularization 02/2020 - 01/2011
7	Multiple Myeloma 01/2021 - 11/2016
6	Amyloid Plaque 05/2018 - 04/2015
3	Transthyretin-Related Hereditary Amyloidosis 11/2021 - 04/2015
3	Paraproteinemias (Monoclonal Gammopathy) 12/2020 - 08/2017
3	Cardiomyopathies (Cardiomyopathy) 12/2019 - 06/2016
3	Inflammation (Inflammations) 05/2019 - 02/2010
3	Proteinuria 05/2018 - 01/2018
3	Atrophy 01/2016 - 01/2010
3	Myopia 11/2015 - 01/2011
3	Carpal Tunnel Syndrome 05/2012 - 12/2008
2	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 05/2019
2	Edema (Dropsy) 09/2021 - 10/2011
2	Macular Edema 09/2021 - 01/2010
2	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2012
2	Renal Insufficiency (Renal Failure) 01/2020 - 05/2012
2	Polyneuropathies (Polyneuropathy) 12/2019 - 09/2012
2	Frailty 05/2018 - 11/2016
2	Epiretinal Membrane (Epiretinal Membranes) 01/2016 - 05/2012
2	Hemorrhage 01/2016 - 10/2011
2	Neoplasms (Cancer) 11/2014 - 06/2006
2	Heart Diseases (Heart Disease) 04/2014 - 12/2011
1	Vision Disorders (Hemeralopia) 09/2022
1	Choroidal Effusions 01/2022
1	Megaloblastic Anemia 01/2022
1	Failure to Thrive 01/2022
1	Ischemia 09/2021
1	Residual Neoplasm 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 01/2021
1	Trifunctional Protein Deficiency With Myopathy And Neuropathy 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Ocular Hypertension (Glaucoma, Suspect) 10/2020
1	Glaucoma 10/2020
1	Hypertension (High Blood Pressure) 10/2020
1	Fibrosis (Cirrhosis) 02/2020
1	Microphthalmos 01/2020
1	Microcephaly 01/2020
1	Ganglion Cysts (Ganglion) 01/2019
1	Diabetes Mellitus 01/2018
1	Infections 01/2017

Drug/Important Bio-Agent (IBA)

17	Amyloid (Amyloid Fibrils)IBA 01/2022 - 04/2015
12	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 11/2022 - 03/2012
12	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2006
11	Biomarkers (Surrogate Marker)IBA 11/2021 - 12/2011
10	Bortezomib (Velcade)FDA Link 01/2022 - 02/2011
9	Retinaldehyde (Retinal)IBA 09/2022 - 10/2011
8	Dexamethasone (Maxidex)FDA LinkGeneric 12/2020 - 02/2011
6	Fluorescein (Funduscein)FDA LinkGeneric 01/2022 - 01/2010
5	pro-brain natriuretic peptide (1-76)IBA 11/2016 - 11/2010
4	Prealbumin (Transthyretin)IBA 11/2021 - 03/2012
4	AntibodiesIBA 01/2021 - 05/2007
4	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2016 - 11/2010
3	Pharmaceutical PreparationsIBA 01/2022 - 05/2007
3	Melphalan (Alkeran)FDA LinkGeneric 10/2020 - 01/2012
3	Lenalidomide (CC 5013)FDA Link 01/2020 - 01/2012
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 03/2013
2	CreatinineIBA 01/2022 - 01/2017
2	AlbuminsIBA 01/2022 - 01/2017
2	daratumumabIBA 01/2021 - 01/2020
2	pomalidomideIBA 12/2020 - 01/2017
2	Bendamustine Hydrochloride FDA Link 11/2018 - 01/2017
2	Amyloidogenic ProteinsIBA 09/2017 - 04/2015
2	Alkylating AgentsIBA 01/2017 - 03/2013
2	Proteasome InhibitorsIBA 01/2017 - 01/2017
2	Immunoglobulin M (IgM)IBA 01/2016 - 02/2011
2	Bevacizumab (Avastin)FDA Link 11/2015 - 01/2012
2	Troponin IIBA 05/2014 - 11/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2012 - 04/2010
1	Hydroxocobalamin FDA Link 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2022
1	Transcobalamins (Transcobalamin II)IBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	3-Hydroxyacyl-CoA DehydrogenaseIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	titanium dioxide (Titania)FDA Link 01/2021
1	Nerve Growth Factor (NGF)IBA 01/2021
1	isatuximabIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2020
1	LipofuscinIBA 01/2020
1	patisiranIBA 12/2019
1	Urokinase Plasminogen Activator ReceptorsIBA 05/2019
1	Growth Differentiation Factor 15IBA 01/2018
1	LatexIBA 10/2017
1	Immunologic Factors (Immunomodulators)IBA 01/2017
1	Immunomodulating AgentsIBA 01/2017
1	Protein Isoforms (Isoforms)IBA 12/2016
1	Adaptor Protein Complex 3IBA 12/2016
1	afliberceptIBA 12/2016

Therapy/Procedure

27	Therapeutics 03/2022 - 12/2006
5	Drug Therapy (Chemotherapy) 01/2020 - 11/2010
2	Aftercare (After-Treatment) 01/2020 - 11/2010
2	Salvage Therapy 01/2017 - 01/2012
2	Lasers (Laser) 10/2011 - 01/2010
1	Hematopoietic Stem Cell Mobilization 01/2020
1	Transplantation 01/2018
1	Radiotherapy 09/2017